Presented September 4th, 2024 at the APSF Stoelting Conference 2024 on “Transforming Anesthetic Care: A Deep Dive into Medication Errors and Opioid Safety”
ABOUT THE SPEAKER(S)
Sevan Kolejian, PharmD, MBA, BCPPS
Director
Division of Mitigation Assessment and Medication Error Surveillance (DMAMES)
Office of Medication Error Prevention and Risk Management (OMEPRM)
Office of Surveillance and Epidemiology (OSE)
Center for Drug Evaluation and Research
U.S. Food and Drug Administration (FDA)
Dr. Kolejian is Director of the Division of Mitigation Assessment and Medication Error Surveillance (DMAMES) within FDA’s Office of Medication Error Prevention and Risk Management (OMEPRM). In her capacity as the Division Director for DMAMES, she provides oversight, coordination, and technical expertise for post-marketing activities involving evaluation of the Risk Evaluation and Mitigation Strategies (REMS) and medication error prevention of regulated drug and drug/device products. She is widely recognized as an expert in medication error prevention, risk mitigation strategies, and program evaluation.
Dr. Kolejian received her undergraduate degree in Biochemistry & Molecular Biology from the University of Maryland Baltimore County, her Doctor of Pharmacy from Virginia Commonwealth University, and Master of Business Administration with concentration in leading organizations from Johns Hopkins University Carey School of Business. She completed an Executive Fellowship in Patient Safety, and has earned certificates in Aging Studies, Drug Development and Regulatory Sciences, Medication Safety, and Pharmacoepidemiology. Before joining FDA, Sevan was a full time clinical pediatric pharmacist and medication safety facilitator at Johns Hopkins Children’s Center in Baltimore, Maryland.
